Why Precision Oncology Is Not Very Precise (and Why This Should Not Surprise Us)
- 8 March 2022
- book chapter
- Published by Springer Nature
- p. 3-21
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Mutational heterogeneity in cancer and the search for new cancer-associated genesNature, 2013
- Clonal evolution in cancerNature, 2012
- Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progressionNature Medicine, 2011
- The influence of a Gene expression profile on breast cancer decisionsJournal of Surgical Oncology, 2009
- Does oncotype DX recurrence score affect the management of patients with early-stage breast cancer?The American Journal of Surgery, 2008
- Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast CancerNew England Journal of Medicine, 2007
- Impact of a Commercial Reference Laboratory Test Recurrence Score on Decision Making in Early-Stage Breast CancerJournal of Oncology Practice, 2007
- Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid LeukemiaNew England Journal of Medicine, 2006
- Population-Based Validation of the Prognostic Model ADJUVANT! for Early Breast CancerJournal of Clinical Oncology, 2005
- Evolutionary dynamics of tumor suppressor gene inactivationProceedings of the National Academy of Sciences, 2004